TY - JOUR
T1 - Population-based Incidence of Myopericarditis After COVID-19 Vaccination in Danish Adolescents
AU - Nygaard, Ulrikka
AU - Holm, Mette
AU - Bohnstedt, Cathrine
AU - Chai, Qing
AU - Schmidt, Lisbeth Samso
AU - Hartling, Ulla Birgitte
AU - Petersen, Jens Jakob Herrche
AU - Thaarup, Jesper
AU - Bjerre, Jesper
AU - Vejlstrup, Niels Grove
AU - Juul, Klaus
AU - Stensballe, Lone Graff
PY - 2022/1
Y1 - 2022/1
N2 - In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
AB - In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.
KW - mRNA COVID-19 vaccine
KW - myopericarditis
KW - adolescents Accepted for publication October 10
KW - 2021
U2 - 10.1097/INF.0000000000003389
DO - 10.1097/INF.0000000000003389
M3 - Letter
C2 - 34889875
VL - 41
SP - E25-E28
JO - Pediatric Infectious Disease Journal
JF - Pediatric Infectious Disease Journal
SN - 0891-3668
IS - 1
ER -